ICCC (Immucell Corp)
Insider Trading Activity
Every open-market purchase and sale reported by ICCC officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-22 | Boekhorst Paul Francis Olivier te | President and CEO | Buy | — | — |
| 2026-04-16 | Paul R Wainman | Director | A | — | — |
| 2026-04-16 | Gloria F Basse | Director | A | — | — |
| 2026-04-16 | David Scott Tomsche | Director | A | — | — |
| 2026-04-16 | Kathy V Turner | Director | A | — | — |
| 2026-04-14 | Bryan K. Gathagan | Director | A | — | — |
| 2026-04-14 | Gloria F Basse | Director | A | — | — |
| 2026-04-14 | Steven T. Rosgen | Director | A | — | — |
| 2026-04-14 | Bobbi Jo Brockmann | VP of Sales and Marketing | A | — | — |
| 2026-04-14 | Paul R Wainman | Director | A | — | — |
| 2026-04-14 | David Scott Tomsche | Director | A | — | — |
| 2026-03-24 | MICHAEL F BRIGHAM | Director | MIXED | — | — |
| 2026-03-23 | Boekhorst Paul Francis Olivier te | President and CEO | A | — | — |
| 2026-01-29 | Timothy C Fiori | Chief Financial Officer | A | — | — |
| 2026-01-29 | Bobbi Jo Brockmann | VP of Sales and Marketing | A | — | — |
| 2026-01-29 | Boekhorst Paul Francis Olivier te | President and CEO | A | — | — |
| 2025-12-04 | Boekhorst Paul Francis Olivier te | President and CEO | Buy | — | — |
| 2025-12-03 | Boekhorst Paul Francis Olivier te | President and CEO | Buy | — | — |
| 2025-11-28 | David Scott Tomsche | Director | Buy | — | — |
| 2025-11-12 | Boekhorst Paul Francis Olivier te | President and CEO | A | — | — |
| 2025-06-13 | Gloria F Basse | Director | M | — | — |
| 2025-06-12 | Bryan K. Gathagan | Director | Buy | — | — |
| 2025-04-23 | Timothy C Fiori | Chief Financial Officer | A | — | — |
| 2024-09-24 | Steven T. Rosgen | Director | A | — | — |
| 2024-09-24 | Paul R Wainman | Director | A | — | — |
| 2024-09-24 | David Scott Tomsche | Director | A | — | — |
| 2024-09-24 | Gloria F Basse | Director | A | — | — |
| 2024-09-24 | Bryan K. Gathagan | Director | A | — | — |
| 2024-08-30 | David Scott Tomsche | Director | D | — | — |
| 2024-08-26 | David Scott Tomsche | Director | D | — | — |
| 2024-08-22 | David Scott Tomsche | Director | D | — | — |
| 2024-08-19 | David Scott Tomsche | Director | D | — | — |
| 2023-09-06 | David Scott Tomsche | Director | D | — | — |
| 2023-08-30 | Bryan K. Gathagan | Director | A | — | — |
| 2023-03-15 | David Scott Tomsche | Director | D | — | — |
| 2023-01-24 | David Cunningham | Director | A | — | — |
| 2023-01-24 | Steven T. Rosgen | Director | A | — | — |
| 2023-01-24 | Gloria F Basse | Director | A | — | — |
| 2023-01-24 | Paul R Wainman | Director | A | — | — |
| 2023-01-24 | David Scott Tomsche | Director | A | — | — |
| 2022-09-12 | David Scott Tomsche | Director | D | — | — |
| 2022-06-16 | David Scott Tomsche | Director | D | — | — |
| 2022-06-14 | David Cunningham | Director | Buy | — | — |
| 2022-05-18 | David Scott Tomsche | Director | D | — | — |
| 2022-05-18 | David Scott Tomsche | Director | D | — | — |
| 2022-03-14 | JOSEPH H CRABB | Former VP and CSO | D | — | — |
| 2022-02-09 | MICHAEL F BRIGHAM | President & CEO | A | — | — |
| 2022-02-09 | Bobbi Jo Brockmann | VP of Sales & Marketing | A | — | — |
| 2022-02-09 | Elizabeth Luttrell Williams | VP of Manufacturing Operations | A | — | — |
| 2021-06-25 | Gloria F Basse | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | — | 650,000 | — |
| — | Director | 514,003 | — |
| — | President & CEO | 205,700 | — |
| — | Former VP and CSO | 142,845 | — |
| — | — | 70,000 | — |
| — | Director | 57,460 | — |
| — | President and CEO | 17,785 | — |
| — | Director | 16,000 | — |
| — | VP of Sales and Marketing | 8,521 | — |
| — | Director | 7,157 | — |
| — | Director | 6,269 | — |
| — | Director | 3,530 | — |
| — | Director | 1,000 | — |
| — | Director | 1,000 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the ICCC quote page; the site-wide leaderboard is on the insider transactions hub.